Ah Equity Partners V, L.L.C. Erasca, Inc. Transaction History

Ah Equity Partners V, L.L.C.

  • $15.4 Million
  • Q3 2022

A detailed history of Ah Equity Partners V, L.L.C. transactions in Erasca, Inc. stock. As of the latest transaction made, Ah Equity Partners V, L.L.C. holds 50,000 shares of ERAS stock, worth $97,500. This represents 2.53% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$97,500
Previous $279,000 39.78%
% of portfolio
2.53%
Previous 1.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$12.51 - $22.75 $125,100 - $227,500
-10,000 Reduced 16.67%
50,000 $779,000
Q3 2021

Nov 12, 2021
BUY
$17.43 - $24.34 $1.05 Million - $1.46 Million
60,000 New
60,000 $1.27 Million

Others Institutions Holding ERAS

# of Institutions
140
Shares Held
229M
Call Options Held
28.7K
Put Options Held
117K
View Full List

About Erasca, Inc.

ERAS Quotes by TradingView
  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $238M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Ah Equity Partners V, L.L.C. Portfolio

Follow Ah Equity Partners V, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ah Equity Partners V, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Ah Equity Partners V, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email